Galiximab
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Galiximab is a monoclonal antibody designed for the treatment of B-cell lymphoma. , it is undergoing Phase III clinical trials. The drug is a chimeric antibody from Macaca irus and Homo sapiens.
Galiximab is a monoclonal antibody designed for the treatment of B-cell lymphoma. , it is undergoing Phase III clinical trials. The drug is a chimeric antibody from Macaca irus and Homo sapiens.
External links
Official website
Text derived from https://en.wikipedia.org/w/index.php?oldid=1160195405 under CC BY-SA 4.0; modifications have been made.